BKI Investment Company (ASX: BKI) – BKI Files FY26 Annual Report
BKI Investment Company reported net profit growth of 4.1% to $64.4 million for the financial year ended 30 June 2026, with earnings per share rising...
ASX Announcements
HVN (ASX: HVN) – HVN Issues Statement on ASIC Case
Harvey Norman Holdings Limited received an adverse Federal Court decision on 28 July 2026 in a case brought by the Australian Securities and...
HVN (ASX: HVN) – HVN Updates ASIC Case Status
The Federal Court of Australia has delivered judgment in ASIC's enforcement action against Harvey Norman Holdings, ordering the company to pay a...
Clinuvel Pharmaceuticals (ASX: CUV) – SCENESSE Phase 3 Vitiligo Trial Update
Clinuvel Pharmaceuticals is advancing SCENESSE, an already-approved drug for a rare blood disorder, into a pivotal Phase III trial for vitiligo...
ALS (ASX: ALQ) – CEO Address and Trading Update
ALS Limited has outlined a refreshed strategic blueprint titled the "Roadmap to Win" that signals a sharpened focus on high-volume analytical...